Cardlytics, Inc. has successfully completed the sale of its Bridg platform to PAR Technology Corporation, as disclosed in their recent Form 8-K filing. The transaction, finalized on March 24, 2026, involved an asset purchase agreement where PAR Technology agreed to acquire all assets related to the Bridg platform. In exchange, Cardlytics received 1,810,222 shares of PAR's common stock. This strategic move is expected to streamline Cardlytics' operations and focus on its core business areas, potentially enhancing its financial performance in the future. The sale was previously announced in a Current Report on Form 8-K filed on January 26, 2026, indicating the company's proactive approach to optimizing its asset portfolio. The completion of this transaction is seen as a positive step for Cardlytics, as it allows the company to concentrate on its primary business objectives while benefiting from the equity stake in PAR Technology. The financial implications of this sale will be reflected in Cardlytics' upcoming financial statements, providing a clearer picture of its operational efficiency and market positioning post-transaction.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.